Using Medical Cannabis for Chronic Pain: A Social-Ecological Framework.

Early studies suggest medical cannabis (MC) has the potential to benefit people who suffer from chronic pain by offering a less addictive alternative to opioids; however, most investigators agree more research is indicated. Today, in 2023, cannabis remains a Schedule I drug and is an illegal substance in the United States under the Controlled Substances Act of 1970. Despite this designation, as of February 2022, 37 states, three territories, and the District of Columbia allowed using cannabis products to treat certain painful medical conditions. The contradictory status of federal and state legislation regarding cannabis use has resulted in delays and restrictions on relevant research. As a result, an inadequate foundation of knowledge exists needed to inform policy, program, and practice decisions concerning MC to treat pain. Implementing and controlling access to MC is influenced by overlapping individual, interpersonal, community, and organizational influences that all fall under the umbrella of federal and state policies. Increasingly, the legalization and expanded access to MC necessitates the integration of evidence, policy, and social-ecological reality. To adequately delineate these complex factors to anticipate and plan future interventions at multiple levels, we propose a social-ecological framework (SEF) for using MC to treat pain. This SEF assumes the transactional relationship between the individual and the environment and that no single factor can predict behavior or health outcomes. Our framework illustrates five dynamic levels of analysis that interact between dimensions. Key elements and intersections are discussed at the intrapersonal, interpersonal, institutional, community, and policy levels.

[1]  E. Mcginty,et al.  Use of Cannabis and Other Pain Treatments Among Adults With Chronic Pain in US States With Medical Cannabis Programs , 2023, JAMA network open.

[2]  Zina Zaslawski,et al.  Medical cannabis in schools: A qualitative study on the experiences of clinicians , 2022, Paediatrics & child health.

[3]  H. Flynn,et al.  Medical Cannabis Patients Report Improvements in Health Functioning and Reductions in Opiate Use , 2022, Substance use & misuse.

[4]  P. Zimbrean,et al.  Cannabinoids and solid organ transplantation: Psychiatric perspectives and recommendations. , 2022, Transplantation reviews.

[5]  R. Pollini,et al.  “The DEA would come in and destroy you”: a qualitative study of fear and unintended consequences among opioid prescribers in WV , 2022, Substance Abuse Treatment, Prevention, and Policy.

[6]  P. Peretti-Watel,et al.  'I trust them because my mum trusts them': Exploring the role of trust in HPV vaccination decision-making among adolescent girls and their mothers in France. , 2022, Vaccine.

[7]  A. Wilson-Poe,et al.  Perceived Efficacy, Reduced Prescription Drug Use, and Minimal Side Effects of Cannabis in Patients with Chronic Orthopedic Pain , 2021, Cannabis and cannabinoid research.

[8]  Liangcheng Yang,et al.  A narrative review on environmental impacts of cannabis cultivation , 2021, Journal of Cannabis Research.

[9]  A. Vigano,et al.  Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process , 2021, Journal of Cannabis Research.

[10]  V. K. Mahabir,et al.  Comparing medical cannabis use in 5 US states: a retrospective database study , 2021, Journal of Cannabis Research.

[11]  J. Whitehill,et al.  Edible Cannabis Exposures Among Children: 2017–2019 , 2021, Pediatrics.

[12]  L. Phillips,et al.  A Multicriteria Decision Analysis Comparing Pharmacotherapy for Chronic Neuropathic Pain, Including Cannabinoids and Cannabis-Based Medical Products , 2021, Cannabis and cannabinoid research.

[13]  W. Hall,et al.  Cannabis use and cannabis use disorder , 2021, Nature Reviews Disease Primers.

[14]  K. Boehnke,et al.  Communication between healthcare providers and medical cannabis patients regarding referral and medication substitution , 2021, Journal of Cannabis Research.

[15]  Shane R Mueller,et al.  Restrictive opioid prescribing policies and evolving risk environments: A qualitative study of the perspectives of patients who experienced an accidental opioid overdose. , 2021, The International journal on drug policy.

[16]  Z. Walsh,et al.  Cannabis Significantly Reduces the Use of Prescription Opioids and Improves Quality of Life in Authorized Patients: Results of a Large Prospective Study. , 2020, Pain medicine.

[17]  H. Johal,et al.  Cannabinoids in the Management of Acute Pain: A Systematic Review and Meta-analysis. , 2020, Cannabis and cannabinoid research.

[18]  Matthew Reid A qualitative review of cannabis stigmas at the twilight of prohibition , 2020, Journal of Cannabis Research.

[19]  V. K. Mahabir,et al.  Medical cannabis use in the United States: a retrospective database study , 2020, Journal of Cannabis Research.

[20]  R. Pollini,et al.  Assessing the impact of a restrictive opioid prescribing law in West Virginia , 2020, Substance Abuse Treatment, Prevention, and Policy.

[21]  R. Isralowitz,et al.  Does religiosity matter? University student attitudes and beliefs toward medical cannabis. , 2020, Complementary therapies in medicine.

[22]  David A. Williams,et al.  High frequency medical cannabis use is associated with worse pain among individuals with chronic pain. , 2020, The journal of pain : official journal of the American Pain Society.

[23]  E. Lombardi,et al.  Ohio physician attitudes toward medical Cannabis and Ohio’s medical marijuana program , 2020, Journal of Cannabis Research.

[24]  Z. Walsh,et al.  The Medical Cannabis Standards Engagement Evaluation and Dissemination (SEED) project: A community-based research approach to self-regulating medical cannabis dispensaries in Canada. , 2020, The International journal on drug policy.

[25]  L. C. Bidwell,et al.  Cannabinoids, Pain, and Opioid Use Reduction: The Importance of Distilling and Disseminating Existing Data. , 2019, Cannabis and cannabinoid research.

[26]  S. Vulfsons,et al.  Predicting Physicians' Intentions to Recommend Medical Cannabis. , 2019, Journal of pain and symptom management.

[27]  K. Humphreys,et al.  Association between medical cannabis laws and opioid overdose mortality has reversed over time , 2019, Proceedings of the National Academy of Sciences.

[28]  L. Squeglia,et al.  Medical Cannabis Use among Adults in the Southeastern United States. , 2019, Cannabis.

[29]  Michelle Newhart The Medicalization of Marijuana , 2018 .

[30]  I. Grant,et al.  Medical cannabis legalization and opioid prescriptions: evidence on US Medicaid enrollees during 1993–2014 , 2018, Addiction.

[31]  G. Newton-Howes The challenges of 'medical cannabis' and mental health: a clinical perspective. , 2018, British journal of clinical pharmacology.

[32]  A. Abraham,et al.  Association Between US State Medical Cannabis Laws and Opioid Prescribing in the Medicare Part D Population , 2018, JAMA internal medicine.

[33]  L. Radbruch,et al.  Cannabis-based medicines for chronic neuropathic pain in adults. , 2018, The Cochrane database of systematic reviews.

[34]  E. Iverson,et al.  Becoming a medical marijuana user. , 2018, The International journal on drug policy.

[35]  E. Romero-Sandoval,et al.  Cannabis and Cannabinoids for Chronic Pain , 2017, Current Rheumatology Reports.

[36]  Virginia T. LeBaron,et al.  The use of cannabis in response to the opioid crisis: A review of the literature. , 2017, Nursing outlook.

[37]  N. Haug,et al.  Cannabis use patterns and motives: A comparison of younger, middle-aged, and older medical cannabis dispensary patients. , 2017, Addictive behaviors.

[38]  B. Piper,et al.  Chronic pain patients' perspectives of medical cannabis , 2017, Pain.

[39]  A. Reiman,et al.  Cannabis as a Substitute for Opioid-Based Pain Medication: Patient Self-Report , 2017, Cannabis and cannabinoid research.

[40]  Brian Johnson,et al.  Cannabis and Pain: A Clinical Review , 2017, Cannabis and cannabinoid research.

[41]  Nehama Lewis,et al.  You Brought it on Yourself: The Joint Effects of Message Type, Stigma, and Responsibility Attribution on Attitudes Toward Medical Cannabis , 2017 .

[42]  Z. Walsh,et al.  Medical cannabis access, use, and substitution for prescription opioids and other substances: A survey of authorized medical cannabis patients. , 2017, The International journal on drug policy.

[43]  B. Betz-Stablein,et al.  Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis , 2017, Neuropsychopharmacology.

[44]  D. Clauw,et al.  Medical Cannabis Use Is Associated With Decreased Opiate Medication Use in a Retrospective Cross-Sectional Survey of Patients With Chronic Pain. , 2016, The journal of pain : official journal of the American Pain Society.

[45]  C. Cuttler,et al.  A Cross-Sectional Survey of Medical Cannabis Users: Patterns of Use and Perceived Efficacy , 2016, Cannabis and cannabinoid research.

[46]  Robert Kay,et al.  Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors. , 2016, Drug and alcohol review.

[47]  Penny F Whiting,et al.  Cannabinoids for Medical Use: A Systematic Review and Meta-analysis. , 2015, JAMA.

[48]  Michael Krawitz Veterans Health Administration Policy on Cannabis as an Adjunct to Pain Treatment with Opiates. , 2015, AMA journal of ethics.

[49]  Roland S. Moore,et al.  Stigma among California’s Medical Marijuana Patients , 2015, Journal of psychoactive drugs.

[50]  C. Cunningham,et al.  Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010. , 2014, JAMA internal medicine.

[51]  Joseph Gregorio Physicians, medical marijuana, and the law. , 2014, The virtual mentor : VM.

[52]  Joan L Bottorff,et al.  Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study , 2013, Harm Reduction Journal.

[53]  M. Côte,et al.  Resilience thinking meets social theory , 2012 .

[54]  Willi Haas,et al.  Sustainable Hospitals: A Socio-Ecological Approach , 2011 .

[55]  D. Cichewicz Synergistic interactions between cannabinoid and opioid analgesics. , 2004, Life sciences.

[56]  D. Stokols Translating Social Ecological Theory into Guidelines for Community Health Promotion , 1996, American journal of health promotion : AJHP.

[57]  Michelle M. Gilmore,et al.  Cannabis and the Environment: What Science Tells Us and What We Still Need to Know , 2021 .

[58]  M. Hannan,et al.  The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[59]  R. Byyny The social determinants of health. , 2012, The Pharos of Alpha Omega Alpha-Honor Medical Society. Alpha Omega Alpha.

[60]  O. Nelson,et al.  The Health Effects of Cannabis and Cannabinoids : The Current State of Evidence and Recommendations for Research Committee on the Health Effects of Marijuana : An Evidence , 2017 .